{"id":"vosoritide-injection","safety":{"commonSideEffects":[{"effect":"Injection site reaction","drugRate":"62.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":92,"totalAffected":57,"trialsReporting":2},{"effect":"Injection site erythema","drugRate":"58.7%","organSystem":"General disorders","placeboRate":"","totalAtRisk":92,"totalAffected":54,"trialsReporting":2},{"effect":"Injection site swelling","drugRate":"27.2%","organSystem":"General disorders","placeboRate":"","totalAtRisk":92,"totalAffected":25,"trialsReporting":2},{"effect":"Nasopharyngitis","drugRate":"26.7%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":16,"trialsReporting":1},{"effect":"Vomiting","drugRate":"26.7%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":16,"trialsReporting":1},{"effect":"Headache","drugRate":"23.3%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":60,"totalAffected":14,"trialsReporting":1},{"effect":"Pyrexia","drugRate":"16.7%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":10,"trialsReporting":1},{"effect":"Injection site urticaria","drugRate":"9.8%","organSystem":"General disorders","placeboRate":"","totalAtRisk":92,"totalAffected":9,"trialsReporting":2},{"effect":"Viral infection","drugRate":"9.8%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":92,"totalAffected":9,"trialsReporting":2},{"effect":"Arthralgia","drugRate":"15.0%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":60,"totalAffected":9,"trialsReporting":1},{"effect":"Upper respiratory tract infection","drugRate":"13.3%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":8,"trialsReporting":1},{"effect":"Fall","drugRate":"7.6%","organSystem":"Injury, poisoning and procedural complications","placeboRate":"","totalAtRisk":92,"totalAffected":7,"trialsReporting":2},{"effect":"Cough","drugRate":"11.7%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":7,"trialsReporting":1},{"effect":"Blood pressure decreased","drugRate":"11.7%","organSystem":"Investigations","placeboRate":"","totalAtRisk":60,"totalAffected":7,"trialsReporting":1},{"effect":"Ear infection","drugRate":"10.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":6,"trialsReporting":1},{"effect":"Otitis media","drugRate":"10.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":6,"trialsReporting":1},{"effect":"Diarrhoea","drugRate":"10.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":6,"trialsReporting":1},{"effect":"Oropharyngeal pain","drugRate":"10.0%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":6,"trialsReporting":1},{"effect":"Ear pain","drugRate":"10.0%","organSystem":"Ear and labyrinth disorders","placeboRate":"","totalAtRisk":60,"totalAffected":6,"trialsReporting":1},{"effect":"Injection site bruising","drugRate":"8.3%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":5,"trialsReporting":1},{"effect":"Influenza","drugRate":"8.3%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":5,"trialsReporting":1},{"effect":"Pain in extremity","drugRate":"8.3%","organSystem":"Musculoskeletal and connective tissue disorders","placeboRate":"","totalAtRisk":60,"totalAffected":5,"trialsReporting":1},{"effect":"Arthropod bite","drugRate":"5.4%","organSystem":"Injury, poisoning and procedural complications","placeboRate":"","totalAtRisk":92,"totalAffected":5,"trialsReporting":2},{"effect":"Fatigue","drugRate":"6.7%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":4,"trialsReporting":1},{"effect":"Injection site mass","drugRate":"6.7%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":4,"trialsReporting":1},{"effect":"Gastroenteritis","drugRate":"6.7%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":4,"trialsReporting":1},{"effect":"Gastroenteritis viral","drugRate":"6.7%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":4,"trialsReporting":1},{"effect":"Dizziness","drugRate":"6.7%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":60,"totalAffected":4,"trialsReporting":1},{"effect":"Seasonal allergy","drugRate":"6.7%","organSystem":"Immune system disorders","placeboRate":"","totalAtRisk":60,"totalAffected":4,"trialsReporting":1},{"effect":"Injection site rash","drugRate":"5.0%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Tonsillitis","drugRate":"5.0%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Abdominal pain","drugRate":"5.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Nausea","drugRate":"5.0%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Constipation","drugRate":"3.3%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":92,"totalAffected":3,"trialsReporting":2},{"effect":"Nasal congestion","drugRate":"5.0%","organSystem":"Respiratory, thoracic and mediastinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Otorrhoea","drugRate":"5.0%","organSystem":"Ear and labyrinth disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Dry skin","drugRate":"5.0%","organSystem":"Skin and subcutaneous tissue disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Vitamin D deficiency","drugRate":"5.0%","organSystem":"Metabolism and nutrition disorders","placeboRate":"","totalAtRisk":60,"totalAffected":3,"trialsReporting":1},{"effect":"Injection site haemorrhage","drugRate":"3.3%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Injection site induration","drugRate":"2.2%","organSystem":"General disorders","placeboRate":"","totalAtRisk":92,"totalAffected":2,"trialsReporting":2},{"effect":"Injection site inflammation","drugRate":"3.3%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Injection site pain","drugRate":"3.3%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Injection site vesicles","drugRate":"3.3%","organSystem":"General disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Bronchitis","drugRate":"3.3%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Enterobiasis","drugRate":"3.3%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Otitis externa","drugRate":"3.3%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Lower respiratory tract infection","drugRate":"2.2%","organSystem":"Infections and infestations","placeboRate":"","totalAtRisk":92,"totalAffected":2,"trialsReporting":2},{"effect":"Paraesthesia","drugRate":"3.3%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Presyncope","drugRate":"3.3%","organSystem":"Nervous system disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1},{"effect":"Abdominal pain upper","drugRate":"3.3%","organSystem":"Gastrointestinal disorders","placeboRate":"","totalAtRisk":60,"totalAffected":2,"trialsReporting":1}],"seriousAdverseEvents":[{"event":"Petit mal epilepsy","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Gastroenteritis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Autism spectrum disorde","detail":"Psychiatric disorders. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Otitis media","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Parainfluenzae virus infection","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Vomiting","detail":"Gastrointestinal disorders. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Skull fracture","detail":"Injury, poisoning and procedural complications. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Respiratory distress","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"3.1%"},{"event":"Influenza","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"1.7%"},{"event":"Radius fracture","detail":"Injury, poisoning and procedural complications. 1 trial(s).","severity":"serious","incidence":"1.7%"},{"event":"Adenoidal hypertrophy","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"1.7%"},{"event":"Sleep apnoea syndrome","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"1.7%"},{"event":"Appendicitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Dyspnoea","detail":"Respiratory, thoracic and mediastinal disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Intracranial pressure increased","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Spinal cord compression","detail":"Nervous system disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Oxygen saturation decreased","detail":"Investigations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Pneumonia","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Respiratory syncytial virus bronchiolitis","detail":"Infections and infestations. 1 trial(s).","severity":"serious","incidence":"0.0%"},{"event":"Sudden infant death syndrome","detail":"General disorders. 1 trial(s).","severity":"serious","incidence":"0.0%"}]},"_chembl":{"chemblId":"CHEMBL3707276","moleculeType":"Protein"},"_sources":{"safety.commonSideEffects":{"url":"","method":"deterministic","source":"ClinicalTrials.gov (2 trials)","rawText":"","confidence":1,"sourceType":"ctgov_results","retrievedAt":"2026-04-20T11:08:29.598333+00:00"}},"_dailymed":null,"_scrapedAt":"2026-03-28T02:57:21.471Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":3,"lastValidatedAt":"2026-04-20T11:08:38.033226+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT04219007","phase":"PHASE2","title":"Vosoritide for Selected Genetic Causes of Short Stature","status":"ACTIVE_NOT_RECRUITING","sponsor":"Andrew Dauber","startDate":"2020-08-04","conditions":"Short Stature","enrollment":56},{"nctId":"NCT07126262","phase":"PHASE2","title":"A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2025-07-30","conditions":"Hypochondroplasia","enrollment":60},{"nctId":"NCT06382155","phase":"PHASE2","title":"A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-10-21","conditions":"Idiopathic Short Stature","enrollment":100},{"nctId":"NCT04554940","phase":"PHASE2","title":"A Clinical Trial to Evaluate Safety of Vosoritide in At-risk Infants With Achondroplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2020-10-10","conditions":"Achondroplasia","enrollment":20},{"nctId":"NCT03424018","phase":"PHASE3","title":"An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2017-12-12","conditions":"Achondroplasia","enrollment":119},{"nctId":"NCT03989947","phase":"PHASE2","title":"An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2019-06-12","conditions":"Achondroplasia","enrollment":73},{"nctId":"NCT02724228","phase":"PHASE2","title":"A Study to Evaluate Long-Term Safety, Tolerability, & Efficacy of BMN 111 in Children With Achondroplasia (ACH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2016-01-26","conditions":"Achondroplasia","enrollment":30},{"nctId":"NCT05845749","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2023-09-25","conditions":"MPS IVA, MPS VI","enrollment":6},{"nctId":"NCT07441876","phase":"PHASE2, PHASE3","title":"A Phase 2/3 Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia","status":"NOT_YET_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2026-02","conditions":"Achondroplasia","enrollment":160},{"nctId":"NCT06668805","phase":"PHASE2","title":"A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment","status":"RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-11-22","conditions":"Short Stature Homeobox- Containing Gene SHOX Deficiency, Noonan Syndrome, Turner Syndrome","enrollment":54},{"nctId":"NCT06455059","phase":"PHASE3","title":"Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BioMarin Pharmaceutical","startDate":"2024-06-17","conditions":"Hypochondroplasia","enrollment":80},{"nctId":"NCT05849389","phase":"PHASE2","title":"Vosoritide for Short Stature in Turner Syndrome","status":"RECRUITING","sponsor":"Roopa Kanakatti Shankar, MBBS, MS","startDate":"2024-04-12","conditions":"Turner Syndrome, Short Stature","enrollment":20},{"nctId":"NCT03583697","phase":"PHASE2","title":"A Clinical Trial to Evaluate the Safety and Efficacy of BMN 111 in Infants and Young Children With Achondroplasia","status":"COMPLETED","sponsor":"BioMarin Pharmaceutical","startDate":"2018-06-13","conditions":"Achondroplasia","enrollment":75},{"nctId":"NCT03197766","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia","status":"COMPLETED","sponsor":"BioMarin Pharmaceutical","startDate":"2016-12-12","conditions":"Achondroplasia","enrollment":121},{"nctId":"NCT01590446","phase":"PHASE1","title":"A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers","status":"COMPLETED","sponsor":"BioMarin Pharmaceutical","startDate":"2012-02","conditions":"Achondroplasia","enrollment":74}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"structuredTrialResults":[{"hr":"","nctId":"NCT03197766","phase":"PHASE3","pValue":"< 0.0001","ciLower":"","ciUpper":"","endpoint":"Change From Baseline in Annualized Growth Velocity (AGV) at Week 52","enrollment":121},{"hr":"0.25","nctId":"NCT03583697","phase":"PHASE2","pValue":"","ciLower":"-0.02","ciUpper":"0.53","endpoint":"Change From Baseline in Height Z-score at Week 52.","enrollment":75}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Vosoritide Injection","genericName":"Vosoritide Injection","companyName":"BioMarin Pharmaceutical","companyId":"biomarin-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":5,"visitCount":1,"trialStats":{"total":2,"withResults":2},"validation":{"fieldsValidated":3,"lastValidatedAt":"2026-04-20T11:08:38.033226+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":false,"safety":true,"trials":true,"score":2}}